Showing 20 of 132 recruiting trials for “frontotemporal-dementia-with-motor-neuron-disease”
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 12 sites📅 Started Aug 2025View details ↗
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Video-Based Proprioceptive Exercise Program in ALS
RecruitingNCT07491484 ↗
Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis
UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
A Study of Ranolazine in ALS
👨⚕️ Jeffrey Statland, MD, University of Kansas Medical Center📍 7 sites📅 Started Apr 2025View details ↗
RecruitingNCT06878235 ↗
Validation of the French Version of the Primary Lateral Sclerosis Functioning Rating Scale (PLSFRS)
Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis
RecruitingNCT06856850 ↗
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
Enrolling by InvitationNCT06875739 ↗
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
RecruitingNCT06803784 ↗
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
Enrolling by InvitationNCT07234851 ↗
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
🏥 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau📍 1 site📅 Started Feb 2025View details ↗
[18F]ACI-19626 PET in TDP-43 Proteinopathies
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
👨⚕️ Ornella Parolini, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 2 sites📅 Started Jan 2025View details ↗
A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
RAPA-501 Therapy for ALS
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →